⌕
Repligen · RGEN · Nasdaq
Tenet 49 · Mixed
Compare
$162.18−0.37%At closeTenet 49 · Mixed
$162.18−0.60 (−0.37%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Repligen (RGEN) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~2.4%/yr (FY21→FY25), net margin 6.6%, and free cash flow (~$93.9M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($M)▲16.4%
738.3
FY21→FY25CAGR +2.4%/yr
Net income ($M)—
48.9
one-off year: see footnoteCAGR −21.4%/yr
Free cash flow ($M)▼37.3%
93.9
FY21→FY25CAGR +16.0%/yr
Diluted EPS—
0.86
FY21→FY25CAGR −21.3%/yr
What the receipts whisper · what a headline number hides
Share count
−1.2%

57.3mn → 56.6mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex
$23.5M

steady at 3.2% of revenue (−8.4% YoY).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)738.3Revenue−352.0COGS386.2Gross profit−54.2R&D−290.5SG&A55.2Op income−6.3Tax & other48.9Net income

7¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
604530150%sector median net margin ~3%FY21FY25

Over this window: gross 58.3% → 52.3%. Net margin 6.6% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
805.6738.3634.4632.4801.5670.5▲16.4%+2.4%
Cost of revenue
374.9352.0359.8353.9345.8279.3▼2.2%+6.0%
Gross profit
430.7386.2274.6278.4455.7391.3▲40.6%−0.3%
Research & development
57.254.243.242.743.934.3▲25.4%+12.1%
Selling, general & admin
312.0290.5263.4218.6215.8183.9▲10.3%+12.1%
Total operating expenses
412.4331.1309.8230.7231.0224.0▲6.9%+10.3%
Operating incomefeeds ROC rank
18.255.2−35.147.7224.7167.2—−24.2%
Other income, net
−10.07.28.19.0−5.5−13.7——
Pretax income
8.262.4−27.056.7219.1153.5—−20.2%
Income tax
20.013.5−1.521.133.225.3—−14.5%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
−11.848.9−25.535.6186.0128.3—−21.4%
Per share
Diluted EPSbuyback-sensitive
−0.200.86−0.460.633.242.24—−21.3%
Diluted shares (mn)
56.5656.5655.9456.3857.4557.26▲1.1%−0.3%
Margins
Gross margin33rd pct in Healthcare
53.5%52.3%43.3%44.0%56.9%58.3%▲9.0pp−6.0pp
Operating margin
2.3%7.5%−5.5%7.5%28.0%24.9%▲13.0pp−17.5pp
Net margin37th pct in Healthcare
−1.5%6.6%−4.0%5.6%23.2%19.1%▲10.6pp−12.5pp
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 37% vs a 16% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 6% vs a 16% norm for this window, likely a one-time item; see the filing.
FY09 – FY20 · 11 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 11 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Repligen's revenue last fiscal year?

Repligen reported revenue of $738.3M in fiscal 2025, up 16.4% from fiscal 2024.

What was Repligen's net income?

Repligen reported net income of $48.9M in fiscal 2025, a net margin of 6.6%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.